SCHEMBL6809550

SCHEMBL6809550

O=[C]Cc1ccc(OCc2cc(Br)cc(Br)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.46
ADAM17 P78536 2/20 0.46
ADAM10 O14672 1/20 0.46
MMP9 P14780 1/20 0.46
APP P05067 1/20 0.45
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
FFAR1 O14842 3/20 0.43
FFAR4 Q5NUL3 2/20 0.43
MAOB P27338 7/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
PARP15 Q460N3 1/20 0.42
PARP14 Q460N5 1/20 0.42
PARP10 Q53GL7 1/20 0.42
MAOA P21397 4/20 0.42
PPARA Q07869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6804479 0.83 MAOB (0.47) APPRXRARXRBMAOBMAOA
SCHEMBL6804913 0.80 PARP10 (0.56) FFAR1FFAR4MAOBPARP10MAOA
SCHEMBL6804907 0.78 MAOB (0.41) ADAM17APPMAOBMAOA
SCHEMBL6803571 0.78 RAB9A (0.40) APPMAOBPARP10MAOA
SCHEMBL6805048 0.77 LMNA (0.58) APPFFAR1FFAR4MAOBCA12
SCHEMBL6804893 0.76 SOD1 (0.42) APPRXRARXRBMAOBPARP10
SCHEMBL9818315 0.75 IDO1 (0.39)
SCHEMBL6799652 0.75 APP (0.58) APPFFAR1FFAR4MAOBMAOA
SCHEMBL6803414 0.75 RAB9A (0.43) APPFFAR1MAOBMRGPRX4
SCHEMBL6809046 0.75 F2 (0.48) APPMAOBPARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770647-B2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-03 US disclosed
WO-2003016248-A2 BICYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$G(A) CONVERTING ENZYME (TACE) BRISTOL-MYERS SQUIBB COMPANY PATENT DEPARTMENT (US) 2003-02-27 WO disclosed